Science Explorer Back to mapMap
Discussion
Researcher · The University of Tokyo · Japan

Hiroyuki Aburatani

Hiroyuki Aburatani publishes mostly in Molecular Biology, Cancer Research and Oncology, on topics such as Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics and RNA modifications and cancer.

ORCID 0000-0003-0438-1544 OpenAlex
World rank
#57,765
of 7,710,434 ranked researchers
Rank in Japan
#323
of 383,136
Works
1,111
Citations
83k
Citations per work
74.5
h-index
131
i10-index 520Top 0.1% in Molecular Biology
Hiroyuki Aburatani

What does Hiroyuki Aburatani research?

Hiroyuki Aburatani's work is mostly in Biochemistry, Genetics and Molecular Biology (51%), Medicine (12%), Immunology and Microbiology (3%).

Life Sciences: 600 works · 54.0% of their workBiochemistry, Genetics and Molecular Biology: 564 works · 50.8% of their workMolecular Biology: 423 works · 38.1% of their workCancer Research: 96 works · 8.6% of their workGenetics: 46 works · 4.1% of their workImmunology and Microbiology: 36 works · 3.2% of their workImmunology: 36 works · 3.2% of their workEverything else: 378 works · 34.0% of their workHealth Sciences: 133 works · 12.0% of their workMedicine: 133 works · 12.0% of their workOncology: 78 works · 7.0% of their workPulmonary and Respiratory Medicine: 56 works · 5.0% of their workTHEIR WORKHiroyukiAburatani1,111works
Life Sciences54%Health Sciences12%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology56450.8%
    2. Immunology and Microbiology363.2%
  2. Everything else37834.0%
    1. Medicine13312.0%
  1. 1Molecular Biology38% of their works
  2. 2Cancer Research9% of their works
  3. 3Oncology7% of their works
  4. 4Pulmonary and Respiratory Medicine5% of their works
  5. 5Genetics4% of their works
  6. 6Immunology3% of their works

Research topics

Which keywords describe Hiroyuki Aburatani's research?

The keywords of their largest research topics: DNA Methylation, Histone Modification, Cancer, Epigenetic Regulation, Cancer Genomics, Mutational Signatures, m6A-seq and RNA methylation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. DNA Methylation1291 topic
  2. Histone Modification1291 topic
  3. Cancer992 topics
  4. Epigenetic Regulation992 topics
  5. Cancer Genomics831 topic
  6. Mutational Signatures831 topic
  7. RNA methylation691 topic
  8. m6A-seq691 topic
  9. Arginine Methylation601 topic
  10. Protein Arginine Methyltransferases601 topic
  11. Chromatin481 topic
  12. Transcription481 topic
  13. Gene Expression421 topic
  14. Microarray421 topic
  15. Long Noncoding RNAs391 topic
  16. RNA Regulation391 topic
  17. Alternative Splicing381 topic
  18. RNA-Binding Proteins381 topic

Where does Hiroyuki Aburatani work?

Hiroyuki Aburatani's main affiliation in the publication record is The University of Tokyo, Japan.

How many publications and citations does Hiroyuki Aburatani have?

OpenAlex counts 1,111 works and 82,744 citations for Hiroyuki Aburatani, an h-index of 131, ranking #57,765 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Hiroyuki Aburatani

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hiroyuki Aburatani. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.